The EBMT activity survey 2008: Impact of team size, team density and new trends

Bone Marrow Transplantation

Volumn 46, Issue 2, 2011, Pages 174-191

  Gratwohl, A ^a   Baldomero, H ^a   Schwendener, A ^b   Gratwohl, M ^b   Apperley, J ^c   Frauendorfer, K ^b   Niederwieser, D ^d  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b UNIVERSITY OF ST GALLEN   (Switzerland)

^c HAMMERSMITH HOSPITAL   (United Kingdom)

^d UNIVERSITY HOSPITAL LEIPZIG   (Germany)

Author keywords

Europe; hematopoietic SCT; stem cell source; team density; transplant rates

Indexed keywords

ARTICLE; BONE MARROW TRANSPLANTATION; DONOR SELECTION; HEALTH CARE PLANNING; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; INTERMETHOD COMPARISON; INTERNATIONAL COOPERATION; LEUKEMIA; LYMPHOMA; PATIENT CARE; PATIENT COUNSELING; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PRIORITY JOURNAL; REDUCED INTENSITY CONDITIONING; SOLID TUMOR; TREATMENT INDICATION; TREND STUDY;

EUROPE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; TISSUE DONORS; TRANSPLANTATION, AUTOLOGOUS; TRANSPLANTATION, HOMOLOGOUS;

EID: 79951678698     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2010.69     Document Type: Article

References (27)

1. Gratwohl A. Bone marrow transplantation activity in Europe 1990. Report from the European Group for Bone Marrow Transplantation (EBMT). Bone Marrow Transplant 1991; 8: 197-201.
2. Gratwohl A, Baldomero H, Horisberger B, Schmid C, Passweg J, Urbano-Ispizua A. Accreditation Committee of the European Group for Blood and Marrow Transplantation (EBMT). Current trends in haematopoietic stem cell transplantation in Europe. Blood 2002; 100: 2374-2386.
3. Copelan EA. Hematopoietic stem-cell transplantation. N Engl J Med 2006; 354: 1813-1826.
4. Appelbaum FR. Hematopoietic-cell transplantation at 50. N Engl J Med 2007; 357: 1472-1475. (Pubitemid 47572632)
5. Gratwohl A, Baldomero H, Schwendener A, Gratwohl M, Apperley J, Niederwieser D, et al., Joint Accreditation Committee of the International Society for Cellular Therapy; European Group for Blood and Marrow Transplantation; European Leukemia Net. Predictability of hematopoietic stem cell transplantation rates. Haematologica 2007; 92: 1679-1686. (Pubitemid 350248248)
6. Gratwohl A, Baldomero H, Schwendener A, Rocha V, Apperley J, Frauendorfer K et al. The EBMT activity survey 2007 with focus on allogeneic HSCT for AML and novel cellular therapies. Bone Marrow Transplant 2009; 43: 275-291.
7. Gini C. Sulla Misura Della Concentrazione e Della Variabilità Dei Caratteri. Atti del R. Istituto Veneto di SS.LL.AA 1914, tome LXXIII. part II, pp. 1203-1248.
8. Gratwohl A, Schwendener A, Baldomero H, Gratwohl M, Apperley J, Niederwieser D et al. Changes in use of hematopoietic stem cell transplantation; a model for diffusion of medical technology. Haematologica 2009 (in press).
9. Gratwohl A, Schmid O, Baldomero H, Horisberger B, Urbano-Ispizua A. Haematopoietic stem cell transplantation (HSCT) in Europe 2002. Changes in indication and impact of team density. A report of the EBMT activity survey. Bone Marrow Transplant 2004; 34: 855-875. (Pubitemid 39562136)
10. Ljungman P, Bregni M, Brune M, Cornelissen J, deWitte T, Dini G et al. European Group for Blood and Marrow. Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: current practicein Europe 2009. Bone Marrow Transplant 2009; 45: 219-234. (e-pub ahead of print).
11. Appelbaum FR. Incorporating hematopoietic cell transplantation (HCT) into the management of adults aged under 60 years with acute myeloid leukemia (AML). Best Pract Res Clin Haematol 2008; 21: 85-92. (Pubitemid 351377515)
12. Cornelissen JJ, van Putten WL, Verdonck LF, Theobald M, Jacky E, Daenen SM et al. Results of a HOVON/SAKK donor versus no-donor analysis of myeloablative HLA-identical sibling stem cell transplantation in first remission acute myeloid leukemia in young and middle-aged adults: benefits for whom? Blood 2007; 109: 3658-3666. (Pubitemid 46641712)
13. Dohner H, Estey EH, Amadori S, Appelbaum FR, Buchner T, Burnett AK et al. Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet. Blood 2009; 115: 453-474.
14. Baccarani M, Cortes J, Pane F, Niederwieser D, Saglio G, Apperley J et al. Chronic myeloid Leukemia: an update of concepts and management recommendations of European LeukemiaNet. J Clin Oncol 2009; 27: 6041-6051.
15. Saussele S, Lauseker M, Gratwohl A, Beelen DW, Bunjes D, Schwerdtfeger R et al. Allogeneic hematopoietic stem cell transplantation (alloSCT) for chronic myeloid leukemia in the imatinib era; evaluation of its impact within a subgroup of the randomized German CML Study IV. Blood 2010; 115: 1880-1885.
16. Cheson BD, Leonard JP. Monoclonal antibody therapy for Bcell non-Hodgkin's lymphoma. N Engl J Med 2008; 359: 613-626.
17. Fish JD, Grupp SA. Stem cell transplantation for neuroblastoma. Bone Marrow Transplant 2008; 41: 159-165. (Pubitemid 351188913)
18. Pedrazzoli P, Rosti G, Secondino S, Carminati O, Demirer T, European Group for Blood and Marrow Transplantation; Solid Tumors Working Party; Gruppo Italiano per il Trapianto di Midollo Osseo, Cellule Staminali Emopoietiche e Terapia Cellulare. chemotherapy with autologous hematopoietic stem cell support for solid tumors in adults. Semin Hematol 2007; 44: 286-295. (Pubitemid 47599547)
19. Gluckman E, Rocha V. Cord blood transplantation: state of the art. Haematologica 2009; 94: 451-454.
20. Bacigalupo A. Aplastic anemia: pathogenesis and treatment. Hematology Am Soc Hematol Educ Program 2007, 23-28. Review.
21. Champlin RE, Schmitz N, Horowitz MM, Chapuis B, Chopra R, Cornelissen JJ et al. Blood stem cells compared with bone marrow as a source of hematopoietic cells for allogeneic transplantation. IBMTR Histocompatibility and Stem Cell Sources Working Committee and the European Group for Blood and Marrow Transplantation (EBMT). Blood 2000; 95: 3702-3709. (Pubitemid 30412840)
22. Frassoni F, Labopin M, Powles R, Mary JY, Arcese W, Bacigalupo A et al. Effect of centre on outcome of bone-marrow transplantation for acute myeloid leukaemia. Acute Leukaemia Working Party of the European Group for Blood and Marrow Transplantation. Lancet 2000; 355: 1393-1398. (Pubitemid 30215961)
23. Karam V, Gunson B, Roggen F, Grande L, Wannoff W, Janssen M et al. Quality control of the European Liver Transplant Registry: results of audit visits to the contributing centers. Transplantation 2003; 75: 2167-2173. (Pubitemid 36793320)
24. Ravanan R, Udayaraj U, Steenkamp R, Ansell D. UK Renal Registry, 11th Annual Report (December 2008): chapter 5 demographics and biochemistry profile of kidney transplant recipients in the UK in 2007: national and centre-specific analyses. Nephron Clin Pract 2009; 111(Suppl 1): c69-c96.
25. Peters C, Ladenstein R, Minkov M, Pötschger U, Gadner H, Cornish J et al. Transplantation activities and treatment strategies in paediatric stem cell transplantation centres: a report from the EBMT Working Party on Paediatric Diseases. European Group for Blood and Marrow Transplantation. Bone Marrow Transplant 1998; 22: 431-437. (Pubitemid 28412472)
26. McKiernan PJ, Baker AJ, Kelly DA. The frequency and outcome of biliary atresia in the UK and Ireland. Lancet 2000; 355: 25-29. (Pubitemid 30072179)
27. Donot PE. JACIE: from guidelines to clinical practice and continuous quality improvement, the Léon-Bérard cancer center experience. Bull Cancer 2009; 96: 797-804. (French).